Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the In-Hospital and 1-Year Outcomes of Patients Without Modifiable Risk Factors Presenting With Acute Coronary Syndrome Undergoing Pci: A Sex-Stratified Analysis
Afshin Amirpour
Afshin Amirpour

Associate Professor of Interventional Cardiology

Department of Cardiology, School of Medicine

Cardiac Rehabilitation Research Center

Cardiovascular Research Institute

Chamran Hospital

Isfahan University of Medical Sciences

Related Documents
1. Factors Affecting Outcome of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction, ARYA Atherosclerosis (2013)
2. The Pragmatic Role of Covid-19 on the Thrombus Grade of Patients With Contemporary St-Segment-Elevation Myocardial Infarction, Journal of Tehran University Heart Center (2022)
3. Association Between St-Segment Changes in Lead Avr and Angiographic Findings, Syntax Score, Short-Term and Intermediate Outcomes in Patients With Acute Coronary Syndrome: A Pilot Study, ARYA Atherosclerosis (2024)
4. Comparison of No-Reflow Phenomenon After Percutaneous Coronary Intervention for Acute Myocardial Infarction Between Smokers and Nonsmokers, Journal of Research in Medical Sciences (2014)
5. Association Between the Platelet-To-Lymphocyte Ratio and the No-Reflow Phenomenon and Thrombolysis in Myocardial Infarction Flow 3 After Primary Percutaneous Coronary Intervention in Patients With St-Segment Elevation Myocardial Infarction, Iranian Heart Journal (2017)
6. The Assessment of No-Reflow Phenomenon Incidence in Early Versus Delayed Percutaneous Coronary Intervention Following a Primary Fibrinolysis, ARYA Atherosclerosis (2024)
7. Blood Group Types and Clinical, Procedural, and Adverse Outcomes in St-Elevated Myocardial Infarction Patients: A 3-Year Cohort in Iran, Journal of Research in Medical Sciences (2023)
8. Effect of Streptokinase on Short-Term Outcomes in the Acute Myocardial Infarction With St-Segment Elevation, Journal of Reports in Pharmaceutical Sciences (2014)
All Documents
1. Antianginal Effects of Empagliflozin in Patients With Type 2 Diabetes And Refractory Angina; a Randomized, Double-Blind Placebo-Controlled Trial (Empt-Angina Trial), Clinical Cardiology (2024)
2. Antianginal Effects of Empagliflozin in Patients With Type 2 Diabetes And Refractory Angina; a Randomized, Double-Blind Placebo-Controlled Trial (Empt-Angina Trial), Clinical Cardiology (2024)
3. Anticoagulant and Antiplatelet Treatment Effects on the Incidence of Major Cardiovascular Events in Patients With Coronary Artery Ectasia: An Updated Systematic Review, Indian Heart Journal (2024)
4. Assessment of Lytic Therapy Effect in Patients With Intermediate-High Risk Pulmonary Embolism for Prevention of Chronic Thromboembolic Pulmonary Hypertension: A Randomized, Double-Blind Trial, Health Science Reports (2024)
5. Assessment of Lytic Therapy Effect in Patients With Intermediate-High Risk Pulmonary Embolism for Prevention of Chronic Thromboembolic Pulmonary Hypertension: A Randomized, Double-Blind Trial, Health Science Reports (2024)
6. Association Between St-Segment Changes in Lead Avr and Angiographic Findings, Syntax Score, Short-Term and Intermediate Outcomes in Patients With Acute Coronary Syndrome: A Pilot Study, ARYA Atherosclerosis (2024)
7. Compare Efficacy and Safety of Autologous Blood Clot Injection With C-Clamp Vascular Closure Device in Treatment of Iatrogenic Pseudoaneurysm After Femoral Artery Puncture, Journal of Vascular Access (2024)
8. Effectiveness and Medication Adherence in Patients With St-Elevated Myocardial Infarction: Persian Polypill Study, ARYA Atherosclerosis (2024)
9. Evaluation of the Efficacy and Safety of Rivaroxaban Compared to Warfarin in Patients With Left Ventricular Apical Thrombus: A Randomized Clinical Trial, Thrombosis Journal (2024)
10. Evaluation of the Efficacy and Safety of Rivaroxaban Compared to Warfarin in Patients With Left Ventricular Apical Thrombus: A Randomized Clinical Trial, Thrombosis Journal (2024)
11. Intramyocardial Dissecting Hematoma: A Systematic Review and Pooled Analysis of Available Literature, ARYA Atherosclerosis (2024)
12. The Assessment of No-Reflow Phenomenon Incidence in Early Versus Delayed Percutaneous Coronary Intervention Following a Primary Fibrinolysis, ARYA Atherosclerosis (2024)
13. Apixaban, a Novel Oral Anticoagulant, Use to Resolute Arterial Patency in Radial Artery Occlusion Due to Cardiac Catheterization; a Pilot Randomized Clinical Trial, ARYA Atherosclerosis (2023)
14. Blood Group Types and Clinical, Procedural, and Adverse Outcomes in St-Elevated Myocardial Infarction Patients: A 3-Year Cohort in Iran, Journal of Research in Medical Sciences (2023)
15. Does Opioid Addiction Influence Clinical and Angiographic Outcomes in Stemi Patients Undergoing Emergency Pci?, Advanced Biomedical Research (2023)
16. Fibrinolytic Therapy in Thrombosis of Mechanical Valves: Outcomes and Complications, ARYA Atherosclerosis (2023)
17. Pneumopericardium in Covid-19 Infection, Iranian Heart Journal (2023)
18. Viewpoints on the Role of Transient Receptor Potential Melastatin Channels in Cardiovascular System and Disease: A Systematic Review, Current Problems in Cardiology (2023)
19. Anethum Graveolens L. (Dill) Effect on Human Lipid Profile: An Updated Systematic Review, Current Problems in Cardiology (2022)
20. Comparison of Pulmonary Emboli Management Between Pulmonary Emboli Response Team and the Conventional Method: The First Study From Iran, Critical Pathways in Cardiology (2022)
21. Comparison of Pulmonary Emboli Management Between Pulmonary Emboli Response Team and the Conventional Method: The First Study From Iran, Critical Pathways in Cardiology (2022)
22. Evaluation of Health Anxiety in Hospital Staff During Covid-19 Pandemic, Journal of Isfahan Medical School (2022)
23. The Effect of Bioenergy Economy on Cardiac Function and Inflammatory Factors in Myocardial Infarction: A Randomized Controlled Trial, International Journal of Body, Mind and Culture (2022)
24. The Pragmatic Role of Covid-19 on the Thrombus Grade of Patients With Contemporary St-Segment-Elevation Myocardial Infarction, Journal of Tehran University Heart Center (2022)
25. The Pragmatic Role of Covid-19 on the Thrombus Grade of Patients With Contemporary St-Segment-Elevation Myocardial Infarction, Journal of Tehran University Heart Center (2022)
26. The Effect of 3-Month Growth Hormone Administration and 12-Month Follow-Up Duration Among Heart Failure Patients Four Weeks After Myocardial Infarction: A Randomized Double-Blinded Clinical Trial, Cardiovascular Therapeutics (2021)
27. A Prospective Study on Gait Dominant Normal Pressure Hydrocephalus, Acta Neurologica Scandinavica (2020)
28. Endothelial Dysfunction in Patients With Lone Atrial Fibrillation, ARYA Atherosclerosis (2020)
29. Resistin and Prooxidant-Antioxidant Balance: Markers to Discriminate Acute Coronary Syndrome From Stable Angina, ARYA Atherosclerosis (2020)
30. Statistical Comments on “Combined Effect of Whole-Body Vibration and Ambient Lighting on Human Discomfort, Heart Rate, and Reaction Time”, International Archives of Occupational and Environmental Health (2020)
31. Vision-Related Quality of Life in Patients With Idiopathic Macular Hole, International Ophthalmology (2020)
32. Comparing Efficacy of Receiving Different Doses of Eptifibatide in Bleeding After Percutaneous Coronary Intervention in Patients With Myocardial Infarction, ARYA Atherosclerosis (2019)
33. Seasonal Variation in Physical Activity in Patients With Heart Failure, Heart and Lung (2019)
34. Statistical Comments on “Ejaculation Effect on Blood Testosterone and Prostatic Pulsed-Wave Doppler Ultrasound in Dogs”, Reproduction in Domestic Animals (2019)
35. Surgical Aortic Valve Replacement Improves Quality of Life; [A Substituicao Cirurgica Da Valvula Aortica Melhora a Qualidade De Vida], Revista Portuguesa de Cardiologia (2019)
36. The Effect of Intracoronary Versus Intralesional Injection of Eptifibatide on Myocardial Perfusion Outcomes During Primary Percutaneous Coronary Intervention in Acute St-Segment Elevation Myocardial Infarction; a Randomized Clinical Trial Study, ARYA Atherosclerosis (2019)
37. Right Ventricular (Rv) Echocardiographic Parameters in Patients With Pulmonary Thromboembolism (Pte), ARYA Atherosclerosis (2018)
38. Serum Interleukin-18 and Extent of Coronary Artery Disease in Unstable Angina, ARYA Atherosclerosis (2018)
39. Association Between the Platelet-To-Lymphocyte Ratio and the No-Reflow Phenomenon and Thrombolysis in Myocardial Infarction Flow 3 After Primary Percutaneous Coronary Intervention in Patients With St-Segment Elevation Myocardial Infarction, Iranian Heart Journal (2017)
40. Development and Validation of Cardiac Patient Competence Questionnaire, Iranian Version, ARYA Atherosclerosis (2015)
41. Comparison of No-Reflow Phenomenon After Percutaneous Coronary Intervention for Acute Myocardial Infarction Between Smokers and Nonsmokers, Journal of Research in Medical Sciences (2014)
42. Effect of Streptokinase on Short-Term Outcomes in the Acute Myocardial Infarction With St-Segment Elevation, Journal of Reports in Pharmaceutical Sciences (2014)
43. Evaluation of Intima Media Thickness of Carotid Arteries in 40-60 Years Old Persons With Type D Personality and Its Comparison With Normal Ones, International Journal of Preventive Medicine (2013)
44. Factors Affecting Outcome of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction, ARYA Atherosclerosis (2013)
45. Lipid Profile in Antipsychotic Drug Users: A Comparative Study, ARYA Atherosclerosis (2013)
46. Predictive Value of P-Wave Duration and Dispersion in Post Coronary Artery Bypass Surgery Atrial Fibrillation, ARYA Atherosclerosis (2012)